Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care Hospital in Karachi: A prospective cohort study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Ahmed, Bilal ^a   Nanji, Kashmira ^a   Mujeeb, Rakshinda ^a   Patel, Muhammad Junaid ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; FEMALE; GERIATRIC PATIENT; HEALTH EDUCATION; HERBAL MEDICINE; HIGH RISK POPULATION; HOMEOPATHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PAKISTAN; POLYPHARMACY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GERIATRICS; TERTIARY CARE CENTER;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GERIATRICS; HUMANS; INCIDENCE; MALE; OUTPATIENTS; PAKISTAN; POLYPHARMACY; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS;

EID: 84912530278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112133     Document Type: Article

References (23)

1. Nobili A, Licata G, Salerno F, Pasina L, Tettamanti M, et al. (2011) Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. European journal of clinical pharmacology 67: 507-519.
2. -(2013) United Nations, Department of Economic and Social Affairs, Population Division (2013) World Population Ageing.
3. Trumic E, Pranjic N, Begic L, Fahir B (2012) Prevalence of Polypharmacy and Drug Interaction Among Hospitalized Patients: Opportunities and Responsabilities in Pharmaceutical Care. Materia socio-medica 24: 68.
4. Steinman MA, Seth Landefeld C, Rosenthal GE, Berthenthal D, Sen S, et al. (2006) Polypharmacy and prescribing quality in older people. Journal of the American Geriatrics Society 54: 1516-1523.
5. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, et al. (2003) Adverse drug reaction risk factors in older outpatients. The American journal of geriatric pharmacotherapy 1: 82-89.
6. Chumney EC, Robinson LC (2006) The effects of pharmacist interventions on patients with polypharmacy. Pharmacy Practice 4: 103-109.
7. Hohl CMl, Dankoff J, Colacone A, Afilalo M (2001) Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Annals of emergency medicine 38: 666-671.
8. Najjar MF, Aziz NA, Hassan Y, Ghazali R, AlRazzaq A, et al. (2010) Predictors of polypharmacy and adverse drug reactions among geriatric in patients at Malaysian hospital. HealthMed 4.
9. Nguyen JK, Fouts MM, Kotabe SE, Lo E (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. The American journal of geriatric pharmacotherapy 4: 36-41.
10. Haider SI, Johnell K, Thorslund M, Fastbom J (2007) Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. International journal of clinical pharmacology and therapeutics 45: 643-653.
11. Sabzwari SR, Qidwai W, Bhanji S (2013) Polypharmacy in elderly: A cautious trail to tread. JPMA The Journal of the Pakistan Medical Association 63: 624-627.
12. Lam DPY, Mak CF, Chan S, Yao RWY, Leung SSY, et al. (2010) Polypharmacy and inappropriate prescribing in elderly Hong Kong Chinese patients. Journal of the American Geriatrics Society 58: 203-205.
13. Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drugâJrelated problems. British journal of clinical pharmacology 63: 187-195.
14. Edwards IR, Aronson JK (2000) Adverse drug reactions: Definitions, diagnosis, and management. The Lancet 356: 1255-1259.
15. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, et al. (2003) Adverse drug events in ambulatory care. New England Journal of Medicine 348: 1556-1564.
16. World Health O (2009) Collaborating centre for drug statistics methodology. Guidelines for ATC classification and DDD assignment 3.
17. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patientsExcess length of stay, extra costs, and attributable mortality. Jama 277: 301-306.
18. Budnitz DS, Shehab N, Kegler SR, Richards CL (2007) Medication use leading to emergency department visits for adverse drug events in older adults. Annals of Internal Medicine 147: 755-765.
19. Thomsen LA, Winterstein AG, SAndergaard B, HaugbĄlle LS, Melander A (2007) Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Annals of Pharmacotherapy 41: 1411-1426.
20. Ernst E (2000) The role of complementary and alternative medicine. BMJ: British Medical Journal 321: 1133.
21. Herman PM, Craig BM, Caspi O (2005) Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complementary and Alternative Medicine 5: 11.
22. Hilmer SN (2008) The dilemma of polypharmacy. Australian Prescriber 31: 2.
23. Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, et al. (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. Journal of the American Geriatrics Society 52: 1349-1354.